Earnings Summary

Biogen Inc.’s revenue fell -4.19% since last year same period to $2353Mn in the Q2 2024. On a quarterly growth basis, Biogen Inc. has generated 6.94% jump in its revenue since last 3-months.

Biogen Inc.’s net profit fell -1.35% since last year same period to $583.6Mn in the Q2 2024. On a quarterly growth basis, Biogen Inc. has generated 48.35% jump in its net profits since last 3-months.

Biogen Inc.’s net profit margin jumped 2.97% since last year same period to 24.8% in the Q2 2024. On a quarterly growth basis, Biogen Inc. has generated 38.72% jump in its net profit margins since last 3-months.

Biogen Inc.’s price-to-earnings ratio after this Q2 2024 earnings stands at 25.45.

Biogen Inc.’s earning per share (EPS) estimates for the current quarter stand at 3.79 - a -5.96% fall from last quarter’s estimates.

Biogen Inc.’s earning per share (EPS) estimates for the current year stand at 3.79.

Biogen Inc.’s earning per share (EPS) jumped 31.34% since last year same period to 5.28 in the Q2 2024. This indicates that the Biogen Inc. has generated 31.34% annual rate of jump in its earning per share (EPS) in the last 4 quarters.

Return on assets (ROA) indicates the profitability of the company in relation to its total assets. This ratio tells the financial health of the company. The higher the ROA, the better the company’s financial health. If any company has a ROA in the range of 5% to 20% - it is generally considered good. ROA above 20% is generally considered excellent. Biogen Inc.’s return on assets (ROA) stands at 0.05.

The Return On Equity ratio indicates a company’s ability to turn equity capital received from shareholders into profits. ROE highlights the efficiency of equity capital in running the business. Generally, a return on equity in double digits is considered good. Biogen Inc.’s return on equity (ROE) stands at 0.08.